Literature DB >> 10758045

Prospective study of potentially virulent strains of Helicobacter pylori and coronary heart disease in middle-aged men.

P Whincup1, J Danesh, M Walker, L Lennon, A Thomson, P Appleby, C Hawkey, J Atherton.   

Abstract

BACKGROUND: Studies are needed to test claims that potentially virulent strains of Helicobacter pylori are more strongly related to coronary heart disease (CHD) than are other strains. METHODS AND
RESULTS: We measured serum IgG antibodies to mixed H pylori antigens and separately to the virulence-associated H pylori antigen CagA (cytotoxin-associated gene product A) in 505 CHD cases and in 1025 age-matched controls "nested" in a prospective study of 7735 British men (mean duration of follow-up in controls, 16 years). Of the 505 cases, 401 (79%) were seropositive for H pylori antibodies compared with 740 (72%) of the 1025 controls, yielding an odds ratio for CHD of 1.55 (95% CI 1.19 to 2.03), which fell to 1.30 (95% CI 0.88 to 1. 90) after adjustments were made for standard vascular risk factors and indicators of socioeconomic status. Of the CHD cases, 240 (48%) were seropositive for IgG antibodies to CagA compared with 450 (44%) of the controls. When CagA-seropositive individuals were compared with H pylori-seronegative individuals, the odds ratio for CHD was 1. 42 (95% CI 1.06 to 1.91), which fell to 1.10 (95% CI 0.71 to 1.71) after adjustments. In an analysis restricted to the 1141 (75%) H pylori-seropositive participants, the odds ratio for CHD was 1.0 (95% CI 0.78 to 1.29) in CagA-seropositive men. No strong associations were observed between H pylori seropositivity and blood lipids, blood pressure, markers of systemic inflammation, or plasma homocysteine.
CONCLUSIONS: H pylori infection is not strongly related to the incidence of CHD in late middle-aged men, and CagA-positive strains appear to be no more strongly related to the disease than other strains. However, further studies are required to confirm or refute the existence of any moderate associations, particularly at younger ages.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10758045     DOI: 10.1161/01.cir.101.14.1647

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  28 in total

Review 1.  Role of infectious and immune factors in coronary and cerebrovascular arteriosclerosis.

Authors:  Claudia Stöllberger; Josef Finsterer
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

2.  Circulatory disease mortality in the Massachusetts tuberculosis fluoroscopy cohort study.

Authors:  Mark P Little; Lydia B Zablotska; Alina V Brenner; Steven E Lipshultz
Journal:  Eur J Epidemiol       Date:  2015-08-09       Impact factor: 8.082

3.  H pylori infection and systemic antibodies to CagA and heat shock protein 60 in patients with coronary heart disease.

Authors:  Cristina Lenzi; Alberto Palazzuoli; Nicola Giordano; Giuliano Alegente; Catia Gonnelli; Maria-Stella Campagna; Annalisa Santucci; Michele Sozzi; Panagiotis Papakostas; Fabio Rollo; Ranuccio Nuti; Natale Figura
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

Review 4.  A review of non-cancer effects, especially circulatory and ocular diseases.

Authors:  Mark P Little
Journal:  Radiat Environ Biophys       Date:  2013-08-01       Impact factor: 1.925

Review 5.  Association between Bacterial Infection and Peripheral Vascular Disease: A Review.

Authors:  Jacek Budzyński; Joanna Wiśniewska; Marek Ciecierski; Anna Kędzia
Journal:  Int J Angiol       Date:  2015-03-23

Review 6.  Role of Helicobacter pylori infection in pathogenesis of atherosclerosis.

Authors:  Rajesh Vijayvergiya; Ramalingam Vadivelu
Journal:  World J Cardiol       Date:  2015-03-26

Review 7.  Helicobacter pylori: Does it add to risk of coronary artery disease.

Authors:  Vishal Sharma; Amitesh Aggarwal
Journal:  World J Cardiol       Date:  2015-01-26

8.  The effect of different strains of Helicobacter pylori on platelet aggregation.

Authors:  Paul A Corcoran; John C Atherton; Steve W Kerrigan; Torkel Wadstrom; Frank E Murray; Richard M Peek; Desmond J Fitzgerald; Dermont M Cox; Michael F Byrne
Journal:  Can J Gastroenterol       Date:  2007-06       Impact factor: 3.522

Review 9.  Clinical significance of Helicobacter pylori infection in patients with acute coronary syndromes: an overview of current evidence.

Authors:  Jacek Budzyński; Marek Koziński; Maria Kłopocka; Julia Maria Kubica; Jacek Kubica
Journal:  Clin Res Cardiol       Date:  2014-05-10       Impact factor: 5.460

10.  Ischaemic heart disease and Cag A strains of Helicobacter pylori in the Caerphilly heart disease study.

Authors:  A F Stone; P Risley; H S Markus; B K Butland; D P Strachan; P C Elwood; M A Mendall
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.